drugset / Trial / NCT07426458
Ventilation and Perfusion in Asthmatics
Phase 4
Recruiting
40 enrolled
University of Miami
Australian Lung Health Initiative Pty Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Timeline
- Start
- 2026-04-27
- Primary completion
- 2028-04
- Completion
- 2028-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albuterol-Budesonide | Unknown | 80 ug | Inhaled |
| Subject | Albuterol-Budesonide | Unknown | 90 ug | Inhaled |
| Subject | Salbutamol | Unknown | 90 ug | Inhaled |